These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 29626721)
21. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats. Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325 [TBL] [Abstract][Full Text] [Related]
22. Nanoparticle assisted solvent selective transdermal combination therapy of curcumin and 5-flurouracil for efficient cancer treatment. Anirudhan TS; Nair AS; Bino SJ Carbohydr Polym; 2017 Oct; 173():131-142. PubMed ID: 28732851 [TBL] [Abstract][Full Text] [Related]
23. Multifunctional Ionic Hydrogel-Based Transdermal Delivery of 5-Fluorouracil for the Breast Cancer Treatment. Pansuriya R; Patel T; Kumar S; Aswal VK; Raje N; Hoskins C; Kailasa SK; Malek NI ACS Appl Bio Mater; 2024 May; 7(5):3110-3123. PubMed ID: 38620030 [TBL] [Abstract][Full Text] [Related]
24. Deformable Vesicles with Edge Activators for the Transdermal Delivery of Non-Psychoactive Cannabinoids. Vettorato E; Fiordelisi M; Ferro S; Zanin D; Franceschinis E; Marzaro G; Realdon N Curr Pharm Des; 2024; 30(12):921-934. PubMed ID: 38482628 [TBL] [Abstract][Full Text] [Related]
25. Selection of high efficient transdermal lipid vesicle for curcumin skin delivery. Zhao YZ; Lu CT; Zhang Y; Xiao J; Zhao YP; Tian JL; Xu YY; Feng ZG; Xu CY Int J Pharm; 2013 Sep; 454(1):302-9. PubMed ID: 23830940 [TBL] [Abstract][Full Text] [Related]
26. Curcumin-loaded nanoliposomes linked to homing peptides for integrin targeting and neuropilin-1-mediated internalization. Kangarlou S; Ramezanpour S; Balalaie S; Roudbar Mohammadi S; Haririan I Pharm Biol; 2017 Dec; 55(1):277-285. PubMed ID: 27937055 [TBL] [Abstract][Full Text] [Related]
27. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer. Li C; Ge X; Wang L Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539 [TBL] [Abstract][Full Text] [Related]
28. Drug-loaded nanoemulsion as positive control is an alternative to DMSO solutions for in vitro evaluation of curcumin delivery to MCF-7 cells. Schultze E; Coradini K; Dos Santos Chaves P; da Silva LP; Buss J; Guterres SS; Collares T; Beck RCR; Pohlmann AR; Seixas FK Pharmacol Rep; 2017 Dec; 69(6):1408-1412. PubMed ID: 29154195 [TBL] [Abstract][Full Text] [Related]
29. Factorial design based curcumin ethosomal nanocarriers for the skin cancer delivery: Peram MR; Jalalpure S; Kumbar V; Patil S; Joshi S; Bhat K; Diwan P J Liposome Res; 2019 Sep; 29(3):291-311. PubMed ID: 30526186 [TBL] [Abstract][Full Text] [Related]
30. An Evaluation of Curcumin-Encapsulated Chitosan Nanoparticles for Transdermal Delivery. Nair RS; Morris A; Billa N; Leong CO AAPS PharmSciTech; 2019 Jan; 20(2):69. PubMed ID: 30631984 [TBL] [Abstract][Full Text] [Related]
31. Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells. Minafra L; Porcino N; Bravatà V; Gaglio D; Bonanomi M; Amore E; Cammarata FP; Russo G; Militello C; Savoca G; Baglio M; Abbate B; Iacoviello G; Evangelista G; Gilardi MC; Bondì ML; Forte GI Sci Rep; 2019 Jul; 9(1):11134. PubMed ID: 31366901 [TBL] [Abstract][Full Text] [Related]
32. Transdermal Delivery of Ondansetron Hydrochloride via Bilosomal Systems: In Vitro, Ex Vivo, and In Vivo Characterization Studies. Ammar HO; Mohamed MI; Tadros MI; Fouly AA AAPS PharmSciTech; 2018 Jul; 19(5):2276-2287. PubMed ID: 29845503 [TBL] [Abstract][Full Text] [Related]
33. Ceramide-2 nanovesicles for effective transdermal delivery: development, characterization and pharmacokinetic evaluation. Gaur PK; Purohit S; Kumar Y; Mishra S; Bhandari A Drug Dev Ind Pharm; 2014 Apr; 40(4):568-76. PubMed ID: 23547761 [TBL] [Abstract][Full Text] [Related]
34. Topical delivery of tetrahydrocurcumin lipid nanoparticles effectively inhibits skin inflammation: in vitro and in vivo study. Kakkar V; Kaur IP; Kaur AP; Saini K; Singh KK Drug Dev Ind Pharm; 2018 Oct; 44(10):1701-1712. PubMed ID: 29938544 [TBL] [Abstract][Full Text] [Related]
35. Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies. Fahmy AM; El-Setouhy DA; Ibrahim AB; Habib BA; Tayel SA; Bayoumi NA Drug Deliv; 2018 Nov; 25(1):12-22. PubMed ID: 29219628 [TBL] [Abstract][Full Text] [Related]
36. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies. Kurakula M; Ahmed OA; Fahmy UA; Ahmed TA J Liposome Res; 2016 Dec; 26(4):288-96. PubMed ID: 26784833 [TBL] [Abstract][Full Text] [Related]
37. Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nanovesicles. Manosroi A; Khositsuntiwong N; Götz F; Werner RG; Manosroi J J Liposome Res; 2009; 19(2):91-8. PubMed ID: 19241277 [TBL] [Abstract][Full Text] [Related]
38. Anti-tumor efficacy of an integrated methyl dihydrojasmonate transdermal microemulsion system targeting breast cancer cells: In vitro and in vivo studies. Yehia R; Hathout RM; Attia DA; Elmazar MM; Mortada ND Colloids Surf B Biointerfaces; 2017 Jul; 155():512-521. PubMed ID: 28486181 [TBL] [Abstract][Full Text] [Related]
39. Topical Delivery of Fenoprofen Calcium via Elastic Nano-vesicular Spanlastics: Optimization Using Experimental Design and In Vivo Evaluation. Farghaly DA; Aboelwafa AA; Hamza MY; Mohamed MI AAPS PharmSciTech; 2017 Nov; 18(8):2898-2909. PubMed ID: 28429293 [TBL] [Abstract][Full Text] [Related]
40. A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line. Tabatabaei Mirakabad FS; Akbarzadeh A; Milani M; Zarghami N; Taheri-Anganeh M; Zeighamian V; Badrzadeh F; Rahmati-Yamchi M Artif Cells Nanomed Biotechnol; 2016; 44(1):423-30. PubMed ID: 25229832 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]